Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Prevalence, indications, and complications of caesarean section in health facilities across Nigeria: a systematic review and meta-analysis.

Tytuł:
Prevalence, indications, and complications of caesarean section in health facilities across Nigeria: a systematic review and meta-analysis.
Autorzy:
Osayande I; School of Human Sciences, University of Greenwich, Old Royal Naval College, Park Row, London, SE10 9LS, UK.
Ogunyemi O; Lagos State Ministry of Health, Ikeja, Lagos, Nigeria.
Gwacham-Anisiobi U; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Olaniran A; Global Health, KIT Royal Tropical Institute, Amsterdam, Netherlands.
Yaya S; School of International Development and Global Studies, Faculty of Social Sciences, University of Ottawa, Ottawa, Canada.; The George Institute for Global Health, Imperial College London, London, UK.
Banke-Thomas A; School of Human Sciences, University of Greenwich, Old Royal Naval College, Park Row, London, SE10 9LS, UK. .; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. .; Maternal and Reproductive Health Research Collective, Lagos, Nigeria. .
Źródło:
Reproductive health [Reprod Health] 2023 Jun 02; Vol. 20 (1), pp. 81. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: [London] : BioMed Central, 2004-
MeSH Terms:
Cesarean Section*/adverse effects
Pregnancy Complications*/epidemiology
Pregnancy ; Female ; Humans ; Prevalence ; Nigeria/epidemiology ; Health Facilities
References:
Lancet. 2018 Oct 13;392(10155):1341-1348. (PMID: 30322584)
Arch Public Health. 2020 Jun 03;78:51. (PMID: 32514347)
Ann Afr Med. 2009 Apr-Jun;8(2):127-32. (PMID: 19805945)
Health Care Women Int. 2017 Jun;38(6):527-543. (PMID: 27611812)
Reprod Health. 2015 Aug 12;12:70. (PMID: 26265149)
Lancet. 2016 Feb 6;387(10018):587-603. (PMID: 26794078)
BMJ Glob Health. 2017 Jul 28;2(2):e000310. (PMID: 29081998)
Int J MCH AIDS. 2020;9(1):128-135. (PMID: 32219011)
Int J Gynaecol Obstet. 2015 Sep;130(3):279-83. (PMID: 26058530)
Lancet. 2019 May 11;393(10184):1973-1982. (PMID: 30929893)
Midwifery. 2011 Oct;27(5):620-7. (PMID: 20630634)
BMC Pregnancy Childbirth. 2014 Jun 30;14:217. (PMID: 24981086)
Niger Med J. 2015 May-Jun;56(3):180-4. (PMID: 26229225)
BMJ Glob Health. 2022 Feb;7(2):. (PMID: 35144921)
Qual Health Res. 2005 Nov;15(9):1277-88. (PMID: 16204405)
J Ayub Med Coll Abbottabad. 2015 Jan-Mar;27(1):151-4. (PMID: 26182763)
Glob Health Action. 2016 Aug 05;9:31880. (PMID: 27498964)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
J Obstet Gynaecol. 2004 Jun;24(4):377-81. (PMID: 15203575)
BMC Pregnancy Childbirth. 2021 Nov 30;21(1):798. (PMID: 34847876)
BMJ Glob Health. 2021 Jun;6(6):. (PMID: 34130991)
Int J Womens Health. 2015 May 13;7:531-8. (PMID: 25999769)
Lancet. 2016 Oct 29;388(10056):2176-2192. (PMID: 27642019)
Afr Health Sci. 2021 Mar;21(1):320-326. (PMID: 34394313)
Trop Med Int Health. 2021 Jul;26(7):775-788. (PMID: 33780090)
Transfusion. 2017 Jan;57(1):36-44. (PMID: 27618767)
Niger J Clin Pract. 2016 Jan-Feb;19(1):18-24. (PMID: 26755213)
Lancet. 2018 Oct 13;392(10155):1349-1357. (PMID: 30322585)
BMJ Glob Health. 2020 Jun;5(6):. (PMID: 32565428)
SAGE Open Med. 2022 Mar 23;10:20503121221085453. (PMID: 35342633)
BMJ Glob Health. 2019 Sep 04;4(5):e001605. (PMID: 31565407)
J Public Health (Oxf). 2021 Apr 13;43(Suppl 1):i1-i3. (PMID: 33856469)
Niger Med J. 2011 Oct;52(4):263-5. (PMID: 22529511)
J Public Health Afr. 2017 Dec 31;8(2):717. (PMID: 29456825)
PLoS One. 2012;7(9):e44484. (PMID: 22962616)
Glob Health Res Policy. 2018 Jul 02;3:19. (PMID: 29988650)
Int J Health Policy Manag. 2021 Sep 01;10(9):564-577. (PMID: 32610819)
J Natl Med Assoc. 2009 Jun;101(6):578-81. (PMID: 19585926)
BMJ Open. 2019 Sep 18;9(9):e025494. (PMID: 31537553)
Ann Med Health Sci Res. 2011 Jan;1(1):77-83. (PMID: 23209958)
Niger J Med. 2009 Apr-Jun;18(2):179-83. (PMID: 19630325)
Pan Afr Med J. 2020 Aug 21;36:317. (PMID: 33193971)
PLoS One. 2017 Mar 29;12(3):e0174369. (PMID: 28355302)
BJOG. 2017 Aug;124(9):1335-1344. (PMID: 28139878)
BMJ Open. 2019 Jun 17;9(6):e027273. (PMID: 31213450)
BMC Pregnancy Childbirth. 2019 Nov 12;19(1):417. (PMID: 31718572)
Afr Health Sci. 2022 Mar;22(1):172-179. (PMID: 36032432)
Int J Gynaecol Obstet. 2021 Feb;152(2):242-248. (PMID: 33098673)
BMJ Open. 2019 Dec 9;9(12):e033348. (PMID: 31822545)
Trop Med Int Health. 2022 May;27(5):494-509. (PMID: 35322914)
Dtsch Arztebl Int. 2015 Jul 20;112(29-30):489-95. (PMID: 26249251)
Health Policy. 2010 Aug;96(3):210-6. (PMID: 20197207)
PLoS One. 2019 Aug 29;14(8):e0221778. (PMID: 31465505)
J Obstet Gynaecol. 2008 Feb;28(2):198-201. (PMID: 18393019)
Br J Anaesth. 2011 Nov;107(5):762-8. (PMID: 21743067)
Contributed Indexing:
Keywords: Caesarean delivery; Complication; Emergency obstetric care; Indication; Nigeria; Prevalence; Systematic review
Entry Date(s):
Date Created: 20230602 Date Completed: 20230605 Latest Revision: 20230605
Update Code:
20240105
PubMed Central ID:
PMC10237076
DOI:
10.1186/s12978-023-01598-9
PMID:
37268951
Czasopismo naukowe
Background: Over 80,000 pregnant women died in Nigeria due to pregnancy-related complications in 2020. Evidence shows that if appropriately conducted, caesarean section (CS) reduces the odds of maternal death. In 2015, the World Health Organization (WHO), in a statement, proposed an optimal national prevalence of CS and recommended the use of Robson classification for classifying and determining intra-facility CS rates. We conducted this systematic review and meta-analysis to synthesise evidence on prevalence, indications, and complications of intra-facility CS in Nigeria.
Methods: Four databases (African Journals Online, Directory of Open Access Journals, EBSCOhost, and PubMed) were systematically searched for relevant articles published from 2000 to 2022. Articles were screened following the PRISMA guidelines, and those meeting the study's inclusion criteria were retained for review. Quality assessment of included studies was conducted using a modified Joanna Briggs Institute's Critical Appraisal Checklist. Narrative synthesis of CS prevalence, indications, and complications as well as a meta-analysis of CS prevalence using R were conducted.
Results: We retrieved 45 articles, with most (33 (64.4%)) being assessed as high quality. The overall prevalence of CS in facilities across Nigeria was 17.6%. We identified a higher prevalence of emergency CS (75.9%) compared to elective CS (24.3%). We also identified a significantly higher CS prevalence in facilities in the south (25.5%) compared to the north (10.6%). Furthermore, we observed a 10.7% increase in intra-facility CS prevalence following the implementation of the WHO statement. However, none of the studies adopted the Robson classification of CS to determine intra-facility CS rates. In addition, neither hierarchy of care (tertiary or secondary) nor type of facility (public or private) significantly influenced intra-facility CS prevalence. The commonest indications for a CS were previous scar/CS (3.5-33.5%) and pregnancy-related hypertensive disorders (5.5-30.0%), while anaemia (6.4-57.1%) was the most reported complication.
Conclusion: There are disparities in the prevalence, indications, and complications of CS in facilities across the geopolitical zones of Nigeria, suggestive of concurrent overuse and underuse. There is a need for comprehensive solutions to optimise CS provision tailor-made for zones in Nigeria. Furthermore, future research needs to adopt current guidelines to improve comparison of CS rates.
(© 2023. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies